Glenmark’s Ryaltris To Reach Western Europe Following Approvals

Indian Firm’s Marketing Plans Include Collaboration With Menarini Group

 
• By Dean Rudge

Glenmark is toasting another launch for the company’s Ryaltris novel treatment for allergic rhinitis, this time with plans to roll the product out in 17 countries across western Europe.

Europe_Map
Glenmark is “concluding the final, national phase of its marketing approval application process.” • Source: Shutterstock

More from Products

More from Generics Bulletin